SG155251A1 - Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof - Google Patents
Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereofInfo
- Publication number
- SG155251A1 SG155251A1 SG200905724-1A SG2009057241A SG155251A1 SG 155251 A1 SG155251 A1 SG 155251A1 SG 2009057241 A SG2009057241 A SG 2009057241A SG 155251 A1 SG155251 A1 SG 155251A1
- Authority
- SG
- Singapore
- Prior art keywords
- benzothiophen
- azetidin
- ethoxy
- propyl
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005090831 | 2005-03-28 | ||
| JP2005174738 | 2005-06-15 | ||
| JP2005206808 | 2005-07-15 | ||
| JP2005230666 | 2005-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG155251A1 true SG155251A1 (en) | 2009-09-30 |
Family
ID=37053344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200905724-1A SG155251A1 (en) | 2005-03-28 | 2006-03-27 | Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7951963B2 (de) |
| EP (4) | EP2210884B1 (de) |
| JP (1) | JP5031554B2 (de) |
| KR (2) | KR101337382B1 (de) |
| CN (1) | CN101151257B (de) |
| AT (2) | ATE557020T1 (de) |
| AU (1) | AU2006229271B2 (de) |
| BR (1) | BRPI0609496C8 (de) |
| CA (2) | CA2799659C (de) |
| CY (3) | CY1112956T1 (de) |
| DK (2) | DK2210884T3 (de) |
| ES (3) | ES2398934T3 (de) |
| IL (2) | IL186044A (de) |
| MX (1) | MX2007011938A (de) |
| NO (3) | NO340071B1 (de) |
| NZ (2) | NZ583580A (de) |
| PL (3) | PL2210884T3 (de) |
| PT (3) | PT2248809E (de) |
| SG (1) | SG155251A1 (de) |
| SI (3) | SI2248809T1 (de) |
| WO (1) | WO2006104088A1 (de) |
| ZA (1) | ZA200708262B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0213393B8 (pt) | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
| SI2248809T1 (sl) * | 2005-03-28 | 2012-09-28 | Toyama Chemical Co Ltd | Alkil-3-(2-(benzo(b)tiofen-5-il)-etoksi)-propanoati kot vmesniki v proizvodnji derivatov azetidin-3-ola |
| JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体 |
| NZ571803A (en) | 2006-04-07 | 2011-12-22 | Vertex Pharma | Amide indole derivatives as modulators of ATP-binding cassette transporters |
| US7645789B2 (en) | 2006-04-07 | 2010-01-12 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| USRE50453E1 (en) | 2006-04-07 | 2025-06-10 | Vertex Pharmaceuticals Incorporated | Indole derivatives as CFTR modulators |
| US10022352B2 (en) | 2006-04-07 | 2018-07-17 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| CA2659835A1 (en) * | 2006-08-04 | 2008-02-07 | Toyama Chemical Co., Ltd. | Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| JP5763313B2 (ja) * | 2009-09-03 | 2015-08-12 | 富山化学工業株式会社 | 2−(1−ベンゾチオフェン−5−イル)エタノールの製造法 |
| JP5592205B2 (ja) * | 2009-09-03 | 2014-09-17 | 富山化学工業株式会社 | (1−ベンゾチオフェン−5−イル)酢酸またはその塩の製造法 |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| ES2608474T3 (es) * | 2010-04-22 | 2017-04-11 | Vertex Pharmaceuticals Incorporated | Proceso de producción de compuestos indol cycloalkylcarboxamido |
| JP6004307B2 (ja) * | 2010-07-26 | 2016-10-05 | 富山化学工業株式会社 | 3−(2−(1−ベンゾチオフェン−5−イル)エトキシ)プロピオン酸の塩またはその水和物およびその製造法 |
| WO2012116942A1 (de) | 2011-03-02 | 2012-09-07 | Bayer Cropscience Ag | Verfahren zur herstellung von aryl- und heteroarylessigsäure-derivaten |
| WO2013047786A1 (ja) | 2011-09-30 | 2013-04-04 | 日本化成株式会社 | 重合性無機粒子分散剤、該重合性無機粒子分散剤を含む無機有機複合粒子、および無機有機樹脂複合材 |
| BR112014020434B1 (pt) * | 2012-02-22 | 2021-10-13 | Fujifilm Toyama Chemical Co., Ltd. | Composição farmacêutica sólida |
| WO2014014841A1 (en) | 2012-07-16 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| BR112016017747A2 (pt) | 2014-01-31 | 2017-08-08 | Toyama Chemical Co Ltd | Agente de intensificação de efeito de reabilitação pós lesão de nervo compreendendo derivados de éter de alquila ou sal do mesmo |
| ES2885181T3 (es) | 2014-04-15 | 2021-12-13 | Vertex Pharma | Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística |
| RU2733381C2 (ru) | 2016-03-31 | 2020-10-01 | Тояма Кемикал Ко., Лтд. | Способ получения 5-(бромметил)-1-бензотиофена |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA844616B (en) | 1983-06-20 | 1986-02-26 | Merck & Co Inc | 2-sulfamoylbenzo(b)thiophene derivatives for the treatment of elevated intraocular pressure |
| NZ208444A (en) | 1983-06-20 | 1987-08-31 | Merck & Co Inc | 2-thiophene derivatives and pharmaceutical compositions |
| US4668697A (en) * | 1983-10-31 | 1987-05-26 | Merck & Co., Inc. | Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor |
| CH673100A5 (de) | 1987-08-10 | 1990-02-15 | Josef Paul Huser | |
| JPH04182463A (ja) | 1990-11-17 | 1992-06-30 | Sumitomo Seika Chem Co Ltd | ハロゲノチオフェノール類およびその誘導体の製造方法 |
| JPH05140086A (ja) | 1991-09-26 | 1993-06-08 | Sumitomo Seika Chem Co Ltd | ハロゲノチオフエノールの製造方法および精製方法 |
| JPH05178816A (ja) | 1991-12-28 | 1993-07-20 | Sumitomo Seika Chem Co Ltd | ハロゲノチオフェノールの製造方法 |
| JP2641363B2 (ja) | 1992-04-22 | 1997-08-13 | 三共株式会社 | 新規なフェネチルアルコール及びその製法 |
| GB9404775D0 (en) | 1994-03-11 | 1994-04-27 | Payne P P Ltd | Improvements in or relating to article tagging |
| JPH08143533A (ja) | 1994-11-24 | 1996-06-04 | Sumitomo Seika Chem Co Ltd | ハロチオフェノール類の製造方法 |
| JPH1043967A (ja) | 1996-08-06 | 1998-02-17 | Calsonic Corp | カシメ装置 |
| AU6519798A (en) | 1997-03-31 | 1998-10-22 | Toyama Chemical Co. Ltd. | Process for producing 2-(benzo{b}thiophen-5-yl)-2-hydroxyacetic acid derivatives, optically active compounds thereof, or salts of both |
| GB9706574D0 (en) | 1997-04-01 | 1997-05-21 | Zeneca Ltd | Cyano substituted cycloalkanes |
| JPH1112238A (ja) | 1997-06-23 | 1999-01-19 | Kao Corp | 1−(β−ヒドロキシエチル)−2,5−ジアミノベンゼン又はその塩の製造法 |
| JPH1143455A (ja) | 1997-07-25 | 1999-02-16 | Mitsubishi Chem Corp | ハロゲン化アルコールの製造方法 |
| AU1506499A (en) | 1997-12-12 | 1999-07-05 | Toyama Chemical Co. Ltd. | Alkyl ether derivatives or salts thereof and calcium antagonists containing the same |
| EP0993105B1 (de) | 1998-10-07 | 2003-01-08 | STMicroelectronics S.r.l. | Leistungsübertragungssteueurung in Sperrwandler durch lastabhängige Austastmodulation |
| JP4182463B2 (ja) | 2000-07-19 | 2008-11-19 | 富士電機デバイステクノロジー株式会社 | 磁気ディスク評価装置およびその方法 |
| WO2002100850A1 (en) | 2001-06-08 | 2002-12-19 | Kuraray Co., Ltd. | Processes for preparation of heterocyclic compounds |
| BRPI0213393B8 (pt) * | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
| ES2391273T3 (es) * | 2003-04-17 | 2012-11-23 | Toyama Chemical Co., Ltd. | Agente preventivo/curativo para enfermedades del nervio retiniano que contiene derivados de éter alquílico o sus sales |
| JP2005012291A (ja) | 2003-06-17 | 2005-01-13 | National Institute Of Information & Communication Technology | Tv会議用モバイル動画通信端末 |
| US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
| WO2005019200A2 (en) * | 2003-08-14 | 2005-03-03 | Icos Corporation | Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof |
| SI2248809T1 (sl) | 2005-03-28 | 2012-09-28 | Toyama Chemical Co Ltd | Alkil-3-(2-(benzo(b)tiofen-5-il)-etoksi)-propanoati kot vmesniki v proizvodnji derivatov azetidin-3-ola |
| CA2648898C (en) | 2006-04-26 | 2015-01-20 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
-
2006
- 2006-03-27 SI SI200631383T patent/SI2248809T1/sl unknown
- 2006-03-27 EP EP10002020A patent/EP2210884B1/de not_active Expired - Lifetime
- 2006-03-27 SI SI200631324T patent/SI2210884T1/sl unknown
- 2006-03-27 PT PT10007872T patent/PT2248809E/pt unknown
- 2006-03-27 KR KR1020127032936A patent/KR101337382B1/ko not_active Expired - Lifetime
- 2006-03-27 ES ES11002265T patent/ES2398934T3/es not_active Expired - Lifetime
- 2006-03-27 ES ES10007872T patent/ES2384312T3/es not_active Expired - Lifetime
- 2006-03-27 DK DK10002020.5T patent/DK2210884T3/da active
- 2006-03-27 BR BRPI0609496A patent/BRPI0609496C8/pt active IP Right Grant
- 2006-03-27 AT AT10007872T patent/ATE557020T1/de active
- 2006-03-27 PT PT10002020T patent/PT2210884E/pt unknown
- 2006-03-27 ZA ZA200708262A patent/ZA200708262B/xx unknown
- 2006-03-27 US US11/909,809 patent/US7951963B2/en active Active
- 2006-03-27 CA CA2799659A patent/CA2799659C/en not_active Expired - Lifetime
- 2006-03-27 AU AU2006229271A patent/AU2006229271B2/en not_active Expired
- 2006-03-27 EP EP11002265A patent/EP2348022B1/de not_active Expired - Lifetime
- 2006-03-27 NZ NZ583580A patent/NZ583580A/en not_active IP Right Cessation
- 2006-03-27 AT AT10002020T patent/ATE546443T1/de active
- 2006-03-27 KR KR1020077024039A patent/KR101283930B1/ko not_active Expired - Lifetime
- 2006-03-27 JP JP2007510482A patent/JP5031554B2/ja not_active Expired - Lifetime
- 2006-03-27 ES ES10002020T patent/ES2380443T3/es not_active Expired - Lifetime
- 2006-03-27 SI SI200631556T patent/SI2348022T1/sl unknown
- 2006-03-27 EP EP10007872A patent/EP2248809B1/de not_active Expired - Lifetime
- 2006-03-27 DK DK10007872.4T patent/DK2248809T3/da active
- 2006-03-27 NZ NZ561672A patent/NZ561672A/en not_active IP Right Cessation
- 2006-03-27 PL PL10002020T patent/PL2210884T3/pl unknown
- 2006-03-27 PT PT110022654T patent/PT2348022E/pt unknown
- 2006-03-27 CA CA2600381A patent/CA2600381C/en not_active Expired - Lifetime
- 2006-03-27 MX MX2007011938A patent/MX2007011938A/es active IP Right Grant
- 2006-03-27 PL PL10007872T patent/PL2248809T3/pl unknown
- 2006-03-27 CN CN2006800102653A patent/CN101151257B/zh not_active Expired - Lifetime
- 2006-03-27 PL PL11002265T patent/PL2348022T3/pl unknown
- 2006-03-27 WO PCT/JP2006/306127 patent/WO2006104088A1/ja not_active Ceased
- 2006-03-27 SG SG200905724-1A patent/SG155251A1/en unknown
- 2006-03-27 EP EP06730075A patent/EP1864978A4/de not_active Withdrawn
-
2007
- 2007-09-12 NO NO20074618A patent/NO340071B1/no unknown
- 2007-09-18 IL IL186044A patent/IL186044A/en active IP Right Grant
-
2011
- 2011-01-06 US US12/985,616 patent/US8273902B2/en not_active Expired - Lifetime
- 2011-07-21 IL IL214245A patent/IL214245A/en active IP Right Grant
-
2012
- 2012-05-08 CY CY20121100434T patent/CY1112956T1/el unknown
- 2012-06-27 CY CY20121100566T patent/CY1112885T1/el unknown
-
2013
- 2013-01-25 CY CY20131100075T patent/CY1113571T1/el unknown
-
2016
- 2016-09-07 NO NO20161419A patent/NO340420B1/no unknown
- 2016-09-07 NO NO20161418A patent/NO340366B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG155251A1 (en) | Process for production of 1-(3-(2-(1-benzothiophen-5-yl)- ethoxy)propyl)azetidin-3-ol or salts thereof | |
| SI1801082T1 (sl) | Postopek za izdelavo anorganskih vlaken | |
| EP2040910A4 (de) | Kalandrierverfahren zur herstellung eines optischen films | |
| ZA200801950B (en) | Regioselective process for preparing benzimidazole thiophenes | |
| PL2088218T3 (pl) | Blacha stalowa gruba o wysokim module Younga i sposób jej wytwarzania | |
| ZA200809453B (en) | Process for producing bleached pulp | |
| PT3061866T (pt) | Processo de fabrico de papel ou cartão | |
| IL199124A (en) | A process for preparing fluoromethyl-converted heterocyclic compounds | |
| ZA200809118B (en) | Process for hydrogen production | |
| ZA200805231B (en) | Process for making diaryl carbonate | |
| IL187155A0 (en) | Process for production of 4-biphenylazetidin-2-ones | |
| SG136920A1 (en) | Process for producing methionine | |
| MX2009012706A (es) | Proceso para preparar triazolonas. | |
| EP2332932A4 (de) | Neue kristalline formen von 4-(2-aminopyridin-4-yl)-3-(4 fluor- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyrazol-methanesulfonat und herstellungsverfahren dafür | |
| FR2910500B1 (fr) | Procede de fabrication d'un papier calque | |
| EP1852436A4 (de) | Verfahren zur herstellung eines cabapenem-derivats und kristallines zwischenprodukt dafür | |
| DK2348022T3 (da) | Fremgangsmåde til fremstilling af 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol eller salte deraf | |
| IL192985A0 (en) | Process for producing optically brightened paper | |
| EP2226325A4 (de) | Verfahren zur herstellung von 4-(substituiertem phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-on | |
| GB0721134D0 (en) | Method for the communication & comparison of the whiteness of paper | |
| PL379536A3 (pl) | Sposób wytwarzania 3-[2-(2-dipropyloaminoetylo)-6-nitrofenylo]-2-oksopropionianu etylu | |
| AU323949S (en) | Paper roll holder |